115 results
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
8 May 24
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights
4:30pm
of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
18 Apr 24
Results of Operations and Financial Condition
4:30pm
within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
12 Apr 24
Regulation FD Disclosure
8:30am
Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation
424B3
INBS
Intelligent Bio Solutions Inc
28 Mar 24
Prospectus supplement
9:00am
of the Private Securities Litigation Reform Act of 1995. These statements are based on our management’s current beliefs, expectations and assumptions about
424B3
nyc2i 13u451i5j
18 Mar 24
Prospectus supplement
1:09pm
8-K
EX-99.2
hl75h67s
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
8-K
EX-10.1
unj2tqm5gf di
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
8-K
EX-99.1
xf7lw03g
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
8-K
EX-99.1
recush5162842j fy8a
29 Feb 24
Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway
5:00pm
8-K
EX-99.1
8mxfs4wjiof3az6z
20 Feb 24
Other Events
5:05pm
8-K
EX-99.1
bxohgkutd1p6a0
9 Feb 24
Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights
5:05pm
8-K
EX-99.1
snxz0twf3l04a89mdc
7 Feb 24
Intelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross Proceeds
5:05pm
8-K
EX-99.1
k9exv2 0s
2 Feb 24
Results of Operations and Financial Condition
5:15pm
8-K
EX-99.1
bxeh7g85qnk1k
30 Jan 24
Regulation FD Disclosure
5:05pm
8-K
EX-99.1
2pamiozhj6e4czrnbka9
26 Jan 24
Intelligent Bio Solutions Inc. Announces Reverse Stock Split
5:05pm
8-K
EX-99.1
kvmt9ks
21 Dec 23
Intelligent Bio Solutions Receives NATA Accreditation for its
5:15pm
8-K
EX-99.1
3jcla
8 Nov 23
Intelligent Bio Solutions Inc. Reports Fiscal 2024 First Quarter Financial Results and Operational Highlights
5:27pm